|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Reginal fat distribution and metabolism in a new mouse model (C57BIJ6) of non - insulin - dependent diabetes mel- litus 显示文摘 | Rebuffe - Scrive M Surwit R Feinglos M | 1993 | Metabolism1993，42，： | 1 |
| 2 | Effects of liraglutide (NN2211), a long-acting GLP-1 analogue, on glycaemic control and bodyweight in subjects with Type 2 diabetes显示文摘 | Feinglos MN Saad MF Pi-sunyer FX | 2005 | Diabete Med2005，22，8： | 1 |
| 3 | Regional Fat Distribution and Metabolism in a New Mouse Model (C57BL/ 6J) of Non-Insulin Dependent Diabetes Mellitus 显示文摘 | Rebuffe-Scrive M Surwit R Feinglos M | 1993 | Metabolism1993，42，11： | 1 |
| 4 | Effect of initial combination therapy with sitagliptin,adipeptidyl peptidase-4 inhibitor, and metformin on glycemiccontrol in patients with type 2 diabetes显示文摘 | GOLDSTEIN B J FEINGLOS M N LUNCEFORD J K etal | 2007 | Diabetes Care2007，30，8： | 1 |
| 5 | Effects of liraglutide(NN2211),a long-acting GLP-1 analogue,on glycaemic control and bodyweight in subjects with type 2 diabetes显示文摘 | Feinglos MN Saad MF Pi-Sunyer FX | 2005 | Diabetic Medicine2005，22，8： | 1 |
| 6 | Therapy of type 2 diabetes, cardio- vascular death, and the UGDP显示文摘 | Feinglos MN Bethel MA | 1999 | American heart journal1999，138，5： | 1 |
| 7 | Stress and diabetes mel- litus 显示文摘 | Surw it RS Schneider MS Feinglos MN | 1992 | Diabetes Care1992，15，10： | 1 |
| 8 | Gestational diabetemellitus显示文摘 | Setji TL Brown AJ Feinglos MN | 2005 | Clin Diabet[J]2005，23，1： | 1 |
| 9 | Effects of liraglutide (NN2211),a long-acting GLP-1 analogue,on glycaemic control and bodyweight in subjects with Type 2 diabetes显示文摘 | Feinglos MN Saad MF Pi-Sunyer FX | 2005 | Diabet Med2005，22，8： | 1 |
| 10 | Effect of initial combination therapy with sitagliptin,a dipeptidyl peptidase-4 inhibitor,and metformin on glycemic control in patients with type 2 diabetes显示文摘 | GOLDSTEIN B J FEINGLOS M N LUNCEFORD J K | | 0，，08： | 1 |
| 11 | ' Insulin' allergy due to zinc 显示文摘 | Feinglos MN Jegasothy BV | 1979 | Lancet1979，20，1： | 1 |
| 12 | Oral agents in the management of type 2 diabetes mellitus显示文摘 | LUNA B FEINGLOS M N | 2001 | American Family Physician2001，63，9： | 1 |
| 13 | Differential effects of fat and sucrose on the development of obesity and diabetes in C57BL/6J and A/J mice显示文摘 | SURWIT R S FEINGLOS M N RODIN J | 1995 | Metabolism1995，44，： | 1 |
| 14 | Basal insulin thempy in type 2 diabetes显示文摘 | Bethel MA Feinglos MN | 2005 | Am Board Fam Pract2005，18，3： | 1 |
| 15 | Effect of initial combination therapy with sitagliptin, a dipeptidyl peptidase-4 inhibitor, and metformin on glycemic control in patients with type 2 diabetes显示文摘 | Goldstein BJ Feinglos MN Lunceford JK | 2007 | Diabetes Care2007，30，： | 1 |
| 16 | Oral agent therapy in the treatment of type 2 diabetes 显示文摘 | Feinglos M N Bethel M A | 1999 | Diabetes Care1999，22，3： | 1 |
| 17 | Effects of liraglutide (NN2211),a long-acting GLP-1 analogue,on glycaemic control and bodyweight in subjects with type 2 diabetes显示文摘 | Feinglos M N | 2005 | Diabetic Medicine2005，22，83： | 1 |
| 18 | Effect of initial combination therapy with sitagliptin,a dipeptidyl peptidase-4 inhibitor,and metformin on glycemic control in patients with type 2 diabetes显示文摘 | Goldstein BJ Feinglos MN Lunceford JK | | 0，，8： | 1 |
| 19 | Gestational diabetes mellitus 显示文摘 | Setji T L Brown A J Feinglos M N | 2005 | Clinical Diabetes2005，23，1： | 1 |
| 20 | Basal insulin therapy in type 2 diabetes显示文摘 | Bethel MA Feinglos MN | 2005 | Am Board Fam Pract2005，18，3： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员